Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
ATB Therapeutics
Antibody therapies developer for oncology and auto-immune disease.
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Organization
Company
CEO
Bertrand Magy
COO
Max Houry
Email Address
info@atbtherapeutics.com
Founded Date
2018
Founder
Bertrand Magy
Max Houry
Industry
Technology
Biology
Biotechnology
Therapeutics
Pharmaceutical industry
Investors
EQT Life Sciences
V-Bio Ventures
MRL Ventures
Sambrinvest
SFPIM
Latest Funding Round Date
November 18, 2024
Latest Funding Round Amount (USD)
56,600,000
Latest Funding Type
Series A
LinkedIn URL
@company/atbtherapeutics
Location
Belgium
Number of Employees (Ranges)
11 – 50
Total Funding Amount (USD)
56,600,000
Twitter URL
@atbtherapeutics
Official Website
atbtherapeutics.com
Find more companies like ATB Therapeutics
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE